Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
11/09/18 8-K Current report filing
Related Documents
7
11/09/18 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
31
11/07/18 8-K Current report filing
Related Documents
5
11/06/18 8-K Current report filing
Related Documents
8
11/05/18 EFFECT Notice of Effectiveness 1
11/05/18 424B3 Prospectus filed pursuant to Rule 424(b)(3) 34
11/02/18 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
46
11/01/18 8-K Current report filing
Related Documents
166
10/31/18 8-K Current report filing
Related Documents
6
10/24/18 S-1 General form of registration statement for all companies including face-amount certificate companies
Related Documents
48